The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long been part of everyday clinical practice.
FDA approves Tris Pharma’s non-stimulant pediatric ADHD liquid medication
The FDA approved Tris Pharma’s Onyda XR to treat ADHD in children who are at least 6 years old. It’s the first liquid non-stimulant ADHD